China International Medical Tourism Co., Ltd.
SERVICE PLATFORM
Integrated Diagnosis and Treatment Platform for International Patients in China
Whole Process Planning
- First walk through illness and demand
- Meeting and admission to the hospital
- Security and immigration fraud
- Employment itinerary
- Follow-up to illness
Expert Consultation
- sick collection collection
- sick translation
- Character meeting
- Viewing session
Local Guide Services
- Collaborative clinic contact box
- Qingding Hotel Residence
- Character meeting
- Conveyance machine and transportation
- Daily life assistance
- Daily travel guide and assistance
Hospital Guide Service
- Designated clinic network
- Collaboration support and management, residential hospital reception management
- Clinic translation
- Collaboration development ticket installation
CAR-T Treatment
- CART Cell Technology Service
Family Accommodation
- 2 people/monthly calculation
- Provided accommodation assistance for foreigners (foreigner public security machine planning registration, foreign capital quality hotel, public housing, residential housing selection)
INTRODUCTION OF TREATMENT REGIMEN
(Equecabtagene Autoleucel Injection) The World’s First Approved Fully-human CAR-T
Approved Indications
Equecabtagene Autoleucel Injection is used to treat adult patients with recurrent or refractory multiple myeloma who have progressed after at least third-line therapy
Note: At least one proteasome inhibitor and one immunomodulatory agent have been used been used
- The world’s first approved fully-human CAR-T Breakthrough fully-human CAR structure: low immunogenicity, long persistence
- China's first approved CAR-T for the treatment of multiple myeloma
- China's first independently researched and fully self-produced CAR-T
Equecabtagene Autoleucel Injection Has Excellent Clinical Efficacy
- Strong tumoricidal
ORR 98.9% ≥CR 82.4% MRD negative rate 97.8%
- Long duration
Median durability 419 days 12-month sustained MRD negative rate 80.8% 12-month PFS rate 85.5%
- Excellent safety
≥ Grade 3 ICANS 0% Incidence of ≥ Grade 3 CRS only 1% No movement/cognitive impairment No Parkinson's disease
- One infusion
Single treatment, return to normal life
IASO Equecabtagene Autoleucel (BCMA CART) NDA approval
Data source:
- 2023 International Myeloma Society Annual Meeting (20th, IMS)
- FUMANBA-1 Clinical Study Data (CTR20192510, NCT05066646)
INTRODUCTION OF TREATMENT CENTERS
We Have a World-Class Medical Center Network Throughout China, Serving Global Patients.
Learn more about the treatment center
INTRODUCTION OF SERVICE PACKAGE
Highlights of the Integrated Service Package for International CAR-T Therapy
CAR-T Therapy Package
Equity and Services
Service Star
Service Team
VIP Service Team
Medical Resources
TOP 10 Hematologic Oncology Hospitals in China
Medical Team
Chief Physicians of Hematology and Their Team
Translation Team
Outpatient + Inpatient + Daily Life (appointment 1 day in advance)
Hospital Admission Examination
International Outpatient Clinic
CAR-T
Equecabtagene Autoleucel Injection
Inpatient Standard
Superior Single Room
Accommodation Standard
Five-Star Hotel (30 Days)
Travel Standard
Business/Luxury Vehicle
During Treatment
VIP Lutong in the Whole Process (expedited on the same day)
Additional Services
Accident Insurance for 2 persons (insurance amount of 200,000)
Core Services Content of International CAR-T Therapy
TOP 10
HematologicOncology Hospitals in China
Consultation during Whole Process
Medical Consultant One-to-one Management during Whole Process
Expert Assessment
TOP 10 Hematologic Oncology Hospitals in China One-to-One Video Consultation with Chief physician
03
Hospitali sation
TOP 10 Hospitals Single Ward and Related Examinations
04
CAR-T Therapy
Equecabtagene Autoleucel Injection
At the 2023 International Myeloma Society (IMS) annual meeting, IASO presented two study results of the CAR-T product Equecabtagene Autoleucel Injection. The updated follow-up data showed that in terms of efficacy, the objective response rate (ORR) for subjects who had not previously received CAR-T therapy reached 98.9%, and the rate of stringent complete response/complete response (sCR/CR) increased to 82.4%.
Accommodation Standard
Hotel Standard
(Arrangement of Temporary Accommodation, and Registration with Public Security Organs for Overseas Personnel)
Travel Standard
Business/Luxury Vehicle
Additional Services
Accident Insurance (Insurance Amount of 200,000)
Guarantee Period
1 Year
Premium
235 Yuan (Premium Scheme)
Age
1-80 Years Old
Medical Deductibles
0 Yuan
Insurance Liability
Insurance Amount (Premium Scheme)
Accidental Death/Disability
200,000 (Maximum)
Compensationfor Medical Expenses
50,000
Compensationfor Medical Expenses of Disease During Domestic Travel
1000
Consolence and Visit Expenses
8000
HospitalizationAllowance
50/day,up to 90 days
24HGlobal Emergency Aid Service
100,000
IndividualResponsibilities During Travel
80,000
TOP 10
HematologicOncology Hospitals in China
Consultation during Whole Process
Medical Consultant One-to-one Management during Whole Process
Expert Assessment
TOP 10 Hematologic Oncology Hospitals in China One-to-One Video Consultation with Chief physician
03
Hospitali sation
TOP 10 Hospitals Single Ward and Related Examinations
04
CAR-T Therapy
Equecabtagene Autoleucel Injection
At the 2023 International Myeloma Society (IMS) annual meeting, IASO presented two study results of the CAR-T product Equecabtagene Autoleucel Injection. The updated follow-up data showed that in terms of efficacy, the objective response rate (ORR) for subjects who had not previously received CAR-T therapy reached 98.9%, and the rate of stringent complete response/complete response (sCR/CR) increased to 82.4%.
Accommodation Standard
Hotel Standard
(Arrangement of Temporary Accommodation, and Registration with Public Security Organs for Overseas Personnel)
Travel Standard
Business/Luxury Vehicle
Five-star Service Package of International CAR-T Therapy
| Service Classification | Service Category | Services Equity |
|---|---|---|
| Appointment Services | ||
| Authoritative Hospitals and Expert Recommendations | ||
| MailingServices for Image FilmSlides | ||
| Appointment of Hospital andExpert | ||
| Appointment of PhysicalExamination for Accompany (Free) | 1 Person | |
| HospitalInvitation Letter | ||
| Hospital CostEstimation Letter | ||
| Assist in VisaProcessing | ||
| Travel Services | ||
| Assist in Booking Round-trip Flight Ticket | ||
| Guidance onOverseas Payment (Alipay Account Registration, Currency Exchange) | ||
| Two Pre-departureOnline Meetings (Contract Guidance + Pre-departureGuidance, including Translation) | ||
| Vehicle Standard | Comfortable Car | |
| Vehicle Service(Hospital-residence Round Trip) | 10 Times | |
| Pick-up or Drop-offServices at DomesticAirports | ||
| Translation Services | ||
| Accompanying and Translation Service in Hospital (Professional Medical Personnel) | 6 Times ( < 4 h/time) | |
| Accompanying and Translation Service in Daily Life | 5 Times ( <4 h/time) | |
| Translation Service in Daily Life (iFlytek Global Translator) Note: A deposit of 5000 yuan is required | 1 Month | |
| Medical Services | ||
| CAR-T Product | Equecabtagene Autoleucel Injection | |
| Basic Treatment | Pre-treatment Evaluation and Related Examinations, T-cell Collection, | |
| Hospitalization | Lymphocyte-clearing Chemotherapy, CAR-T Reinfusion, Evaluation 6 Weeks (without ICU) | |
| Local Services | ||
| Accommodation Arrangement (Foreign-related Hotels, registration with Public Security Bureau) | Five-star Hotels for 30 days | |
| Mobile Phone for Communication (with Social Software such as Whatsup, Facebook and Application Software such as Alipay, Translation Software) Note: A deposit of 5000 yuan is required | 1 Month | |
| Local SIM Card (Free Telephone Fee) | RMB 300 | |
| Medical Document Translation Service (Discharge Summary in English) | ||
| Information Inquiry Report of Related Disease (Free) | ||
| Assist in Visa Extension | ||
| Assistance with Hospital Settlement and Refund Guidance | ||
| Assistance with Hotel Lease Termination Procedures | ||
| Assistance with Arranging Return Matters | ||
| Assistance with Mailing Hospital Bills |
SERVICE PROCESS
Integrated diagnosis and treatment services for international patients in China
Learn more about the Car-T Treatment Process
ABOUT US
China International Medical Tourism Co., Ltd.
An institution that provides global customers with advanced medical technology services and solutions for medical fee payment
- The company cooperates with hospitals in China, Japan, the United States, and other regions to assist patients with international travel and receiving medical services quipped with advanced technology.
- As a global medical platform, the company integratesglobal oncologist and new drugs and technologies, helping thousands of patientswith tumors in China, the United States, and Japan to receive new drugs andtechnologies consultation and treatment every year, and also assists numerousinternational patients to go to China for anticancer therapies such as CAR-T,TILs, and cancer vaccines.
An antitumor assistant for patients with tumors
A medical platform for oncologist
A close partner of innovative antitumor drug manufacturers
Continue to fight cancers hand in hand with global patients, and conquer cancer as early as possible!
Jointly Creating an Integrated CAR-T Treatment Service Platform for International Patients
Providing Global Patients with High-quality CAR-T Treatment Experiences and Hopes for Cure
Didn't find the information you needed?
Contact us immediately to resolve your issue via Email or phone.
INQUIRY NOW